-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
in Oncology |
|
Submit your manuscript
Scope
Surgical Oncology incorporates the advances in the innovative surgical techniques to primary tumors in the frame work of multi-modality treatments. The two last decades have witnessed an explosion in minimally invasive techniques, such as video-assisted and robotically-assisted resections that have not only reduced morbidity and mortality, but have also improved the patients quality of life and have extended the surgical indications to the elderly patients. In addition, novel modalities, such as CT-directed radiofrequency ablation (RFA) or stereotactic body radiotherapy (SBRT) have arisen as synergistic therapies to surgery, while oncoplastic surgery is extending its role in certain organ pathologies. This section's mission is dissemination of quality manuscripts that detail important advances in the local therapy of cancers. Reports on all types of solid tumors will be reviewed by an extensive panel of world-class associate editors to assure quality and diversity in the manuscript selected for publication. Cancer treatment has become highly interdisciplinary and complex and it relies on the expertise of many specialists. Surgical Oncology is an open access specialty that aims at publishing the best research across the entire field of surgical oncology. The specialty welcomes outstanding contributions in any domain of cancer research: from basic laboratory research to clinical investigation, from prevention to treatment and from imaging to novel treatment strategies.Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Surgical Oncology welcomes submissions of the following article types: Book Review, Case Report, Clinical Trial, Correction, Data Report, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Surgical Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Surgical Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology and Surgery.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01